Celularity Inc. Files 8-K on Material Agreements
Ticker: CELUW · Form: 8-K · Filed: May 20, 2025 · CIK: 1752828
Sentiment: neutral
Topics: material-agreement, equity-sale
Related Tickers: CELU
TL;DR
Celularity filed an 8-K on 5/20/25 for material agreements & equity sales.
AI Summary
On May 20, 2025, Celularity Inc. filed an 8-K report detailing a material definitive agreement and unregistered sales of equity securities. The company, formerly known as GX Acquisition Corp., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates significant corporate actions, including new agreements and equity transactions, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — Filings related to material definitive agreements and unregistered sales of equity can signal significant corporate changes or financial activities that may carry inherent risks.
Key Players & Entities
- Celularity Inc. (company) — Registrant
- GX Acquisition Corp. (company) — Former company name
- May 20, 2025 (date) — Date of earliest event reported
FAQ
What specific material definitive agreement was entered into by Celularity Inc. on or before May 20, 2025?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What type of unregistered sales of equity securities were made by Celularity Inc. on or before May 20, 2025?
The filing mentions unregistered sales of equity securities, but the specifics of these sales are not detailed in the provided text.
When was Celularity Inc. formerly known as GX Acquisition Corp. and when did the name change occur?
Celularity Inc. was formerly known as GX Acquisition Corp., and the date of the name change was September 12, 2018.
What is Celularity Inc.'s Standard Industrial Classification (SIC) code and industry?
Celularity Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the business and mailing address for Celularity Inc. as reported in the filing?
The business and mailing address for Celularity Inc. is 170 Park Ave, Florham Park, New Jersey, 07932.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 20, 2025 regarding Celularity Inc (CELUW).